DCTD Programs
Last Updated: 09/14/2020
Funding Opportunity Announcements (FOAs)
Funding Opportunities through DCTD’s Programs
Visit the websites of DCTD's individual programs for more information on currently available funding opportunities.
- Cancer Diagnosis Program
- Cancer Imaging Program
- Cancer Therapy Evaluation Program
- Developmental Therapeutics Program
- Radiation Research Program
- Translational Research Program
- Office of Cancer Complementary and Alternative Medicine
Title | Announcement Number | Opening Date |
Expiration Date | Activity Code |
---|---|---|---|---|
Glioblastoma Therapeutics Network (Clinical Trial Required) | RFA-CA-20-047 | October 19, 2020 | November 20, 2020 | U19 |
NCI Clinical and Translational Exploratory/Developmental Studies (Clinical Trial Optional) | PAR-20-292 | September 20, 2020 | July 21, 2022 | R21 |
Title | Announcement Number | Opening Date |
Expiration Date | Activity Code |
---|---|---|---|---|
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (Clinical Trials Not Allowed) | RFA-CA-20-017 | January 21, 2020 | September 30, 2020 | R21 |
Assay Validation of High Quality Markers for Clinical Studies in Cancer (Clinical Trial Not Allowed) | PAR-18-317 PAR-18-310 |
January 14, 2018 |
October 9, 2020 |
UH2/UH3 UH3 |
Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (Clinical Trial Optional) | RFA-CA-19-034 | May 19, 2019 |
October 19, 2020 |
P20 |
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (Clinical Trial Required) | PAR-18-560 | February 15, 2018 |
January 8, 2021 |
R01 |
Academic Research Enhancement Award (Clinical Trial Required) | PA-18-343 | January 25, 2018 | January 8, 2021 | R15 |
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (Clinical Trial Optional) | PAR-18-841 | October 19, 2018 | June 15, 2021 | U24 |
Revision Applications for Mechanisms of Cancer Drug Resistance (Clinical Trial Not Allowed) | RFA-CA-19-049 RFA-CA-19-050 RFA-CA-19-051 RFA-CA-19-052 RFA-CA-19-053 |
September 24, 2019 | June 24, 2021 | R01 U01 U54 P01 P50 |
Small Cell Lung Cancer (SCLC) Consortium: Biology, Therapy and Resistance (Clinical Trial Not Allowed) | PAR-19-361 | October 12, 2019 | March 12, 2022 | U01 |
Microbial-based Cancer Therapy - Bugs as Drugs (Clinical Trial Not Allowed) | PAR-19-193 | May 16, 2019 | May 8, 2022 | R01 |
Microbial-based Cancer Therapy - Bugs as Drugs (Clinical Trial Not Allowed) | PAR-19-194 | May 16, 2019 | May 8, 2022 | R21 |
Revision Applications for Validation of Biomarker Assays Developed through NIH-Supported Research Grants (Clinical Trial Not Allowed) | PAR-20-074 | January 28, 2020 |
October 29, 2022 |
R01 |
Title | Announcement Number | Opening Date |
Expiration Date | Activity Code |
---|---|---|---|---|
Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (Clinical Trial Optional) | PAR-18-950 | November 15, 2018 | December 12, 2020 | X02 |
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (Clinical Trial Optional) | PAR-18-530 | February 28, 2018 |
January 8, 2021 |
R01 |
Opportunities for Collaborative Research at the NIH Clinical Center (Clinical Trial Optional) | PAR-18-951 | March 15, 2019 | April 16, 2021 | U01 |
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (Clinical Trial Optional) | PA-18-738 | May 5, 2018 |
May 8, 2021 |
R01 |
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (Clinical Trial Optional) | PA-18-739 | May 16, 2018 |
May 8, 2021 |
R21 |
Bioengineering Research Grants (BRG) (Clinical Trial Required) | PAR-19-159 | January 8, 2019 |
May 8, 2021 |
R01 |
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (Clinical Trial Optional) | PA-18-902 | September 5, 2018 |
September 8, 2021 |
R01 |
Bioengineering Research Grants (BRG) (Clinical Trial Not Allowed) | PAR-19-158 | January 8, 2019 |
January 8, 2022 |
R01 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (Clinical Trial Not Allowed) | PAR-19-149 | January 16, 2019 |
January 8, 2022 |
R21 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (Clinical Trial Optional) | PAR-19-150 | January 16, 2019 |
January 8, 2022 |
R21 |
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (Clinical Trial Not Allowed) | PAR-19-375 | January 16, 2020 | January 8, 2023 | R03 |
Mechanisms and Consequences of Sleep Disparities in the U.S. (Clinical Trial Not Allowed) | PAR-20-164 | June 12, 2020 | July 15, 2022 | R01 |
Grantsmanship Resources – NCI
- NCI-wide Funding
- NCI Office of Grants Administration
- NCI Division of Extramural Activities
- The NCI Grants Process
- Guidelines and Tools for Clinical Protocol Development
Grantsmanship Resources – NIH
- NIH Parent Announcements
- Office of Extramural Research
- Grant Application Basics
- Center for Scientific Review
- Small Business Funding Opportunities
- New and Early Stage Investigator Policies